Anthropometric traits are of global clinical relevance as risk factors for a wide 8 range of disease, including obesity 1,2 . Yet despite many hundreds of genetic variants having 9 been associated with anthropometric measurements, these variants still explain little 10 variation of the traits 3,4 . Joint-modeling of multiple anthropometric traits, has the potential 11 to boost discovery power, but has not been applied to global-scale meta-analyses of 12 genome-wide association studies (meta-GWAS). Here, we develop a simple method to 13 perform multi-trait meta-GWAS using summary statistics reported in standard single-trait 14 meta-GWAS and replicate the findings in an independent cohort. Using the summary 15 statistics reported by the GIANT consortium meta-GWAS of 270,000 individuals 5 , we 16 discovered 359 novel loci significantly associated with six anthropometric traits. The 17 "overeating gene" GRM5 (P = 4.38×10 -54 ) was the strongest novel locus 6-8 , and was 18 independently replicated in the Generation Scotland cohort (n = 9,603, P = 4.42×10 -3 ). The 19 novel variants had an enriched rediscovery rate in the replication cohort. Our results 20 provide new important insights into the biological mechanisms underlying anthropometric 21 traits and emphasize the value of combining multiple correlated phenotypes in genomic 22 studies. Our method has general applicability and can be applied as a secondary analysis of 23 any standard GWAS or meta-GWAS with multiple traits. 24 25
rs669724 on S in the GIANT population as 0.0068 (s.e. = 0.0004) based on the MANOVA test 66 statistic, which indicates that rs669724 explains 0.68% variance-covariance of the six traits (see 67 Methods). For comparison, we estimated the phenotype score of the FTO locus. The top variant 68 rs11642841 (MAF = 0.45, P = 5.88×10 -56 ) at the FTO locus explains only 0.37% of the variance-69 covariance of the six traits. This indicated that the information measured by the six 70 anthropometric traits captured by the GRM5 rare variant rs669724 is nearly twice as much as that 71 by the FTO variant rs11642841.
73
In the recently available Generation Scotland cohort 14 , which was not a part of the GIANT 74 analysis, we computed the same phenotype score S for 9,603 individuals, using the above 75 coefficients estimated in the GIANT population. The allelic dosages of rs669724 were extracted, 76 with a MAF of 0.003 and imputation R-square 0.77. With such a low MAF, the power of 77 replication was limited; nevertheless, the genetic effect of rs669724 on S was replicated with a p-78 value of 4.42×10 -3 (Table 1) . Given the effect size and standard error in the GIANT population, 79 and MAF in the Generation Scotland cohort, we estimated the 95% confidence interval of the 80 replication p-value in the Generation Scotland cohort should be (0.0029, 0.0211), which covers 81 our replication p-value.
83
Although the molecular mechanism of the multiple GRM5 intron variants is unclear, our finding 84 is consistent with previous reports. A large CNV (duplication) with length about 5.1Mb at the 85 GRM5 locus was found amongst those enriched in obese subjects 7 . The expression of GRM5 in 86 obese mice was significantly higher than lean mice 8 . The antagonist of GRM5, MTEP 87 (C 11 H 8 N 2 S), was shown to reduce overeating in baboons 6 .
89
The strength of the GRM5 multi-trait association in the GIANT meta-analysis favored 90 replication, but we lacked sufficient power to specifically replicate other individual findings after 91 correction for multiple testing. Nevertheless, we conducted the same replication procedure 92 4 (coefficients to construct phenotype scores given in Supplementary Table 1 ) and obtained the 93 replication p-values for all the newly associated SNPs. In order to examine whether our method 94 mapped true signals, we computed the rediscovery rates (RDR) 15 of these loci in the Generation 95 Scotland cohort ( Figure 2) . The RDR is defined as the proportion of SNPs replicable in the 96 replication cohort at 5% significance threshold, given a particular p-value threshold in the 97 discovery meta-GWAS that determines which SNPs are passed onto replication analysis.
98
Assuming the size of each SNP effect is the same in the discovery and replication populations, 99 we also computed the expected RDR in the Generation Scotland cohort given its sample size and 100 allele frequencies. The results showed that our RDR across all the novel SNPs had an 101 enrichment, not only compared to the null, but also better than the expectation when a stringent 102 discovery threshold is applied.
104
Besides the GRM5 locus, we also investigated the published biological evidence among the 25 105 novel meta-GWAS loci that had a p-value less than 2×10 -16 (observed RDR larger than or equal 106 to expected). More than half of these loci harbor candidate genes with reported relevance to 107 obesity or obesity-associated disease ( Supplementary Table 1 -2). For instance, very recent 108 evidence shows that IRF5 (rs15498, P = 1.90×10 -20 ) controls mass of adipose tissue depots and 109 insulin sensitivity in obesity 16 . TGFBR2 (rs6794685, P = 3.05×10 -19 ) is a receptor of TGF-beta 110 which is closely associated with BMI, obesity and type 2 diabetes 17 . HDAC9 (rs11770723, P = 111 3.38×10 -19 ) leads to obesity-induced body fat dysfunction and metabolic disease during high-fat 112 feeding in mice 18 , and recently, similar behaviors have been reported for AHR at the same 113 locus 19 .
115
According to the Genetic Association of Complex Diseases and Disorders (GAD) database, 252 116 genes at the novel loci were previously found to be associated with different types of disease, 117 e.g. metabolic, cardiovascular, psychiatric diseases and cancer ( Supplementary Table 5 .4).
118
When we conducted high-throughput functional annotation analysis using DEPICT 20 for the 119 novel loci, but no clear enrichment of functional gene sets were found ( Supplementary Table   120 5.2). This is consistent with results from loci identified in the single-trait meta-GWAS, for which 121 no significant gene set enrichment was found at a false discovery rate (FDR) threshold of 5%.
122
However, when combining the multi-trait and single-trait loci together, 7 gene sets showed FDR 123 5 < 5%, including MP:0009395 that regulates nucleated erythrocyte cell number, MP:0004810 that 124 regulates hematopoietic stem cell number, and three GO items (GO:0040008, GO:0001558, 125 GO:0045926) which all regulate growth ( Supplementary Table 8 .5).
127
Our analysis substantially improved the power of mapping novel variants by combining 128 correlated traits, which is analog to combining repeated measurements of a single trait. With 129 such power, we observed novel discoveries across different MAF values, but most of the novel 130 variants had low MAF ( Supplementary Fig. 2 ). Thus, we expect that more rare variants than 131 common ones can be detected if the sample size meta-GWAS increases.
133
We conclude that constructing a combined phenotype score from directly measured traits adds 134 statistical power to detect additional loci and explain missing heritability. The modified 135 MANOVA statistic is a highly practical method that can be readily applied to any number of Our analysis translates each SNP-multi-trait association into a single additive effect parameter, 142 so that replication of the genetic effect is meaningful. This is the major advantage of our method 143 compared to previous tools 10,11 . The demonstration of equivalence between MANOVA test 144 statistic and this additive effect is also statistically novel.
146
With our results, we emphasize the value of combining multiple related phenotypes in large-147 scale genomic studies. We expect immediate application of our method to the massive available 148 meta-GWAS summary statistics from different global-scale consortia, which would substantially 149 boost the discovery power and reveal more interesting biological knowledge for multiple 150 complex traits. Table 9 and Supplementary Fig. 5-6 ).
450
Functional annotation 451 We conducted high-throughput functional annotation of the novel discoveries. For prioritizing 452 genes in associated regions, gene set enrichment and tissue/cell type enrichment, we used the 453 DEPICT software 20 . We first analyzed the loci that were found using single-trait GWAS only, 454 then we analyzed all the loci that were found using the MV approach, thereafter we analyzed all 455 these loci together ( Supplementary Table 5 -8) . In each step, we applied two thresholds: P < 456 1×10 -9 and P < 1×10 -16 , in order to compare the results at different RDR (see main text). 
